Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy

The high fatality of patients with blast phase (BP) chronic myeloid leukemia (CML) necessitates identification of high-risk (HR) patients to prevent onset of BP. Here, we investigated the risk of BP based on additional chromosomal abnormality (ACA) profiles in a cohort of 2326 CML patients treated w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Adv
Huvudupphovsmän: Gong, Zimu, Medeiros, L. Jeffrey, Cortes, Jorge E., Chen, Zi, Zheng, Lan, Li, Yan, Bai, Shi, Lin, Pei, Miranda, Roberto N., Jorgensen, Jeffrey L., McDonnell, Timothy J., Wang, Wei, Kantarjian, Hagop M., Hu, Shimin
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2017
Ämnen:
Myeloid Neoplasia
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728641/
https://ncbi.nlm.nih.gov/pubmed/29296906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011858
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk